Key facts
- Notable investors include First Move Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Levive Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Levive Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Levive Labs
Developer of longevity-focused wellness products designed for personalized health optimization purposes. The company's platform analyzes saliva based DNA and epigenetic data through a secure lab process, applies artificial intelligence to assess aging-related biomarkers and epigenetic indicators, generates a customized longevity dashboard and supplement plan, offers consultations with doctors, nutritionists, and biohackers, includes bio-age tracking and testing tools, enabling individuals seeking to optimize lifespan, reverse biological aging, and make informed health decisions to access a comprehensive, data-driven, and actionable longevity program.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Singapore, Singapore
- Founded
- 2023
- Employees
- 5
- Website
- levivelabs.com/
- Ownership
- Privately Held (backing)
Levive Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Levive Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Levive Labs in its N-PORT filings yet. We sweep new filings monthly.